Sonoma Pharmaceuticals, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
SNOA on Nasdaq
Location
5445 Conestoga Court, Suite 150, Boulder, CO

There are no Buy or Sell transactions made by insiders since 4/23/2024

Sonoma Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Mclaughlin Director Jan 2, 2025
Bruce Thornton Executive VP & COO Jan 2, 2025
Jerome Dvonch Chief Financial Officer Jan 2, 2025
Jay E. Birnbaum Director Jan 2, 2025
Chad N. White Chief Financial Officer Dec 29, 2022
John Dal Controller Jan 2, 2025
Philippe Weigerstorfer Director Jan 2, 2025
Amy Trombly Chief Executive Officer Jan 2, 2025

Recent Insider Transactions by Companies or Individuals for Sonoma Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.